Automated MR-based lung volume segmentation in population-based whole-body MR imaging: correlation with clinical characteristics, pulmonary function testing and obstructive lung disease

[1]  Chin-Chou Wang,et al.  Impact of overweight and obesity on acute exacerbations of COPD – subgroup analysis of the Taiwan Obstructive Lung Disease cohort , 2017, International journal of chronic obstructive pulmonary disease.

[2]  T. H. Nguyen,et al.  Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Respiratory medicine.

[3]  H. Watz,et al.  Chronic obstructive pulmonary disease , 2017, The Lancet.

[4]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.

[5]  Tahreema N. Matin,et al.  Chronic Obstructive Pulmonary Disease: Lobar Analysis with Hyperpolarized 129Xe MR Imaging. , 2017, Radiology.

[6]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. , 2017, American journal of respiratory and critical care medicine.

[7]  E. Marchiori,et al.  Whole-body MRI in pediatric patients with cancer , 2017, Cancer Imaging.

[8]  V. Brusasco,et al.  2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung , 2017, European Respiratory Journal.

[9]  M. Bottai,et al.  Body height as risk factor for emphysema in COPD , 2016, Scientific Reports.

[10]  W. Rathmann,et al.  Subclinical Disease Burden as Assessed by Whole-Body MRI in Subjects With Prediabetes, Subjects With Diabetes, and Normal Control Subjects From the General Population: The KORA-MRI Study , 2016, Diabetes.

[11]  H. Kauczor,et al.  Early detection and sensitive monitoring of CF lung disease: Prospects of improved and safer imaging , 2016, Pediatric pulmonology.

[12]  L. Fayad,et al.  Current whole-body MRI applications in the neurofibromatoses , 2016, Neurology.

[13]  M. Reiser,et al.  Population-Based Imaging and Radiomics: Rationale and Perspective of the German National Cohort MRI Study , 2016, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[14]  F. Lecouvet.  Whole-Body MR Imaging: Musculoskeletal Applications. , 2016, Radiology.

[15]  J. Seo,et al.  The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease , 2015, Journal of Korean medical science.

[16]  N. Michoux,et al.  The Increasing Spectrum of Indications of Whole-Body MRI Beyond Oncology: Imaging Answers to Clinical Needs , 2015, Seminars in Musculoskeletal Radiology.

[17]  J. Linseisen,et al.  Whole-Body MR Imaging in the German National Cohort: Rationale, Design, and Technical Background. , 2015, Radiology.

[18]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[19]  Wei Zhang,et al.  Lung Volume Change After Pedicle Subtraction Osteotomy in Patients With Ankylosing Spondylitis With Thoracolumbar Kyphosis , 2015, Spine.

[20]  B. Hamm,et al.  Automated lung volumetry from routine thoracic CT scans: how reliable is the result? , 2014, Academic radiology.

[21]  M. Kersten,et al.  Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET , 2013, European Radiology.

[22]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[23]  M. Puderbach,et al.  MRI of the lung (1/3): methods , 2012, Insights into Imaging.

[24]  Katrin Hegenscheid,et al.  A fast and accurate automatic lung segmentation and volumetry method for MR data used in epidemiological studies , 2012, Comput. Medical Imaging Graph..

[25]  David Price,et al.  Spirometry: an essential tool for screening, case-finding, and diagnosis of COPD. , 2012, Primary care respiratory journal : journal of the General Practice Airways Group.

[26]  M. Puderbach,et al.  MRI of the lung (2/3). Why … when … how? , 2012, Insights into Imaging.

[27]  G. Beluffi,et al.  MRI of the lung , 2010, La radiologia medica.

[28]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[29]  P. Leander,et al.  Validity of apparent diffusion coefficient hyperpolarized 3He-MRI using MSCT and pulmonary function tests as references. , 2009, European journal of radiology.

[30]  S. Ladd.  Whole-body MRI as a screening tool? , 2009, European journal of radiology.

[31]  Wim Timens,et al.  The pathology of chronic obstructive pulmonary disease. , 2009, Annual review of pathology.

[32]  C. Jenkins.  COPD management. Part I. Strategies for managing the burden of established COPD. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[33]  K. Larsson,et al.  Low awareness of COPD among physicians , 2008, The clinical respiratory journal.

[34]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[35]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[36]  R Holle,et al.  KORA - A Research Platform for Population Based Health Research , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[37]  J. Hankinson,et al.  General considerations for lung function testing , 2005, European Respiratory Journal.

[38]  S. Guerra,et al.  The relation of body mass index to asthma, chronic bronchitis, and emphysema. , 2002, Chest.

[39]  S. Rennard,et al.  COPD in 2001: a major challenge for medicine, the pharmaceutical industry, and society. , 2002, Chest.

[40]  T. Gotoh,et al.  Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema , 2002, European Respiratory Journal.

[41]  K. Esato,et al.  Interactions of regional respiratory mechanics and pulmonary ventilatory impairment in pulmonary emphysema: assessment with dynamic MRI and xenon-133 single-photon emission CT. , 2000, Chest.

[42]  K. Suga,et al.  Respiratory failure and pulmonary hypertension associated with Klippel-Feil syndrome , 1999, Annals of nuclear medicine.

[43]  M Thelen,et al.  Assessment of lung volumes using helical CT at inspiration and expiration: comparison with pulmonary function tests. , 1998, AJR. American journal of roentgenology.

[44]  T. Petty,et al.  Screening and early intervention for COPD. , 1998, Hospital practice.

[45]  R M Slone,et al.  MR analysis of lung volume and thoracic dimensions in patients with emphysema before and after lung volume reduction surgery. , 1998, AJR. American journal of roentgenology.

[46]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[47]  S. Doğan,et al.  MRI of pneumonia in immunocompromised patients: comparison with CT. , 2017, Diagnostic and interventional radiology.

[48]  E. Ford,et al.  Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. , 2015, Chest.

[49]  James T.C. Li,et al.  Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. , 2015, Allergy and asthma proceedings.

[50]  T Hielscher,et al.  Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance , 2014, Leukemia.